Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2019-02-06 | 2019-02-25 | 74894 |
BACKUP PLAN ONESTEP | 1.5MG | TABLET | Resolved | 2019-02-13 | 2019-02-21 | 75635 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-15 | 2019-02-21 | 72363 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-13 | 2019-02-21 | 75617 |
APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2018-05-15 | 2019-02-21 | 49481 |
APO-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2019-01-08 | 2019-02-14 | 71475 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2019-01-09 | 2019-02-13 | 71659 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2019-01-30 | 2019-02-13 | 74014 |
APO-OXYCODONE CR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-18 | 2019-02-08 | 69921 |
APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71139 |
APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2019-01-09 | 2019-02-08 | 71673 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2018-11-30 | 2019-02-08 | 68218 |
APO-BACLOFEN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71115 |
APO-BACLOFEN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71107 |
APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-10-02 | 2019-02-06 | 62868 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2018-10-19 | 2019-02-06 | 64956 |
APO-TIMOP GEL | 0.5% | SOLUTION | Resolved | 2017-03-11 | 2019-02-05 | 510 |
APO-TIMOP | 0.5% | SOLUTION | Resolved | 2018-05-08 | 2019-02-05 | 48866 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-01 | 67404 |
APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2019-01-30 | 2019-02-01 | 74022 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
APO-PROPRANOLOL | 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1163 |
APO-NORTRIPTYLINE | 25MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1155 |